These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2884547)

  • 1. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder.
    Buchsbaum MS; Wu J; Haier R; Hazlett E; Ball R; Katz M; Sokolski K; Lagunas-Solar M; Langer D
    Life Sci; 1987 Jun; 40(25):2393-400. PubMed ID: 2884547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of regional brain metabolic responses to lorazepam.
    Wang GJ; Volkow ND; Overall J; Hitzemann RJ; Pappas N; Pascani K; Fowler JS
    J Nucl Med; 1996 Oct; 37(10):1609-13. PubMed ID: 8862292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography.
    Wu JC; Gillin JC; Buchsbaum MS; Hershey T; Hazlett E; Sicotte N; Bunney WE
    Sleep; 1991 Apr; 14(2):155-62. PubMed ID: 1866529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder.
    Buchsbaum MS; Hazlett E; Sicotte N; Stein M; Wu J; Zetin M
    Biol Psychiatry; 1985 Aug; 20(8):832-42. PubMed ID: 2862924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose.
    London ED; Cascella NG; Wong DF; Phillips RL; Dannals RF; Links JM; Herning R; Grayson R; Jaffe JH; Wagner HN
    Arch Gen Psychiatry; 1990 Jun; 47(6):567-74. PubMed ID: 2350209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral glucose metabolic differences in patients with panic disorder.
    Nordahl TE; Semple WE; Gross M; Mellman TA; Stein MB; Goyer P; King AC; Uhde TW; Cohen RM
    Neuropsychopharmacology; 1990 Aug; 3(4):261-72. PubMed ID: 2400544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET in generalized anxiety disorder.
    Wu JC; Buchsbaum MS; Hershey TG; Hazlett E; Sicotte N; Johnson JC
    Biol Psychiatry; 1991 Jun; 29(12):1181-99. PubMed ID: 1888800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
    Aden GC; O'Hair DE
    Clin Ther; 1980; 3(3):209-18. PubMed ID: 6109568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clorazepate on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Eimer M; Cable T; Gal P; Rothenberger LA; McCue JD
    J Fam Pract; 1985 Nov; 21(5):359-62. PubMed ID: 2865326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clorazepate on depressed mood in anxious patients.
    Zung WW
    J Clin Psychiatry; 1987 Jan; 48(1):13-4. PubMed ID: 2879832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD; Szelies B; Kessler J; Herholz K
    Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder.
    Bremner JD; Innis RB; Ng CK; Staib LH; Salomon RM; Bronen RA; Duncan J; Southwick SM; Krystal JH; Rich D; Zubal G; Dey H; Soufer R; Charney DS
    Arch Gen Psychiatry; 1997 Mar; 54(3):246-54. PubMed ID: 9075465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain glucose utilization in adenylosuccinase-deficient patients measured by positron emission tomography.
    De Volder AG; Jaeken J; Van den Berghe G; Bol A; Michel C; Cogneau M; Goffinet AM
    Pediatr Res; 1988 Aug; 24(2):238-42. PubMed ID: 3263613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of the effects of the benzodiazepine derivative clorazepate on corticosterone secretion with its behavioural actions. Antagonism by Ro 15-1788.
    Mormede P; Dantzer R; Perio A
    Pharmacol Biochem Behav; 1984 Dec; 21(6):839-43. PubMed ID: 6151666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in myotonic dystrophy.
    Mielke R; Herholz K; Fink G; Ritter D; Heiss WD
    Psychiatry Res; 1993 Jun; 50(2):93-9. PubMed ID: 8378492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolism in mitochondrial encephalomyopathy: a PET study.
    De Volder A; Ghilain S; de Barsy T; Goffinet AM
    J Comput Assist Tomogr; 1988; 12(5):854-7. PubMed ID: 3262636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
    Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clorazepate and lorazepam: clinical improvement and rebound anxiety.
    Rickels K; Fox IL; Greenblatt DJ; Sandler KR; Schless A
    Am J Psychiatry; 1988 Mar; 145(3):312-7. PubMed ID: 2894175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine combined with clorazepate dipotassium and behaviour modification for treatment of anxiety-related disorders in dogs.
    Pineda S; Anzola B; Olivares A; Ibáñez M
    Vet J; 2014 Mar; 199(3):387-91. PubMed ID: 24439470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.